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Abstract  The  paper  tries  to  answer  two  questions:  the  safety  of  the  injection  of  gadolinium
during breastfeeding;  the  value  of  a  breast  MRI  in  the  nursing  mother  if  breast  cancer  is  sus-
pected. Recent  Anglo-Saxon  publications  are  in  favour  of  continued  breastfeeding  following
the injection  of  gadolinium.  In  fact,  only  a  minute  quantity  of  contrast  product  passes  into
the mother’s  milk,  much  less  than  the  threshold  recommended  in  paediatrics  in  the  infant.
However,  a  suspension  of  lactation  for  24  h  after  the  injection  of  gadolinium  chelate  is  still
recommended  in  France.  The  literature  is  poor  as  regards  the  contribution  of  the  MRI  during
lactation,  although  the  data  indicates  that  the  MRI  is  contributory,  in  spite  of  the  physiological
changes in  the  breast  during  this  period.  In  fact,  all  of  the  lesions  have  been  visualised  and
correctly classiﬁed  according  to  the  BI-RADS  classiﬁcation  by  the  ACR1.  However,  the  semiology
is speciﬁc  and  has  to  be  known.
© 2012  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Pregnancy-associated  breast  carcinoma  (PABC)  occurs  during  a  period  ranging  from  the
beginning  of  a  pregnancy  to  one  year  after  delivery.  It  is  not  rare  and  strikes  between
0.2  and  3%  of  all  breast  cancers  [1],  or  350  to  750  women  per  year  in  France  [2,3]. The
frequency  of  PABC  is  increasing,  in  part  due  to  a  later  ﬁrst  pregnancy  (mean  of  29.8  years
in  2007  versus  24  years  in  1970  in  France).  The  prognosis  of  these  cancers  is  often  poor  as
they  are  detected  at  a  more  evolved  stage  with  only  30%  of  the  tumours  under  2  cm  and
61%  N+  (versus  50%  and  28%  respectively  in  a  control  population  of  the  same  age)  [3].  A
recent  article  examined  the  impact  of  pregnancy  on  breast  cancers  occurring  before  the
age  of  35.  The  tumours  of  the  patients  pregnant  during  the  year  following  the  diagnosis
were  larger,  more  often  with  an  invasion  of  the  lymph  glands  [4].
1 http://www.acr.org/SecondaryMainMenuCategories/quality safety/BIRADSAtlas/BIRADSAtlasexcerptedtext/BIRADSMRIFirstEdition.aspx
xxxinvasion of the lymph glands.
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The  negativity  of  the  hormonal  receptors,  the  positivity
f  HER  2/neu,  the  SBR  II  or  III  grade  of  these  tumours  is  also
requent.  It  is  difﬁcult  to  determine  whether  these  progno-
tic  factors  are  only  related  to  the  young  age  of  the  patients
r  whether  the  pregnancy  favours  them  [2,3].
With  lactation,  the  breast  acquires  its  ﬁnal  differenti-
tion  and  these  changes  are  also  visible  in  the  different
maging  usually  used  in  senology.  Sonography,  the  reference
xamination  during  pregnancy  and  breastfeeding,  remains
fﬁcient  in  the  diagnosis  of  masses  [5].  In  addition  to  their
iagnosis  and  the  characterisation,  it  allows  for  indispens-
ble  guided  biopsies  or  the  monitoring  of  their  evolution
uring  neoadjuvant  chemotherapy.  The  sonographic  semio-
ogy  of  the  masses  does  not  seem  to  change  during  lactation.
his  technique  is  currently  the  gold  standard  in  the  explo-
ation  of  breast  anomalies  in  the  nursing  woman.  The
ecreased  sensitivity  of  the  mammography  is  known  dur-
ng  this  period.  The  increased  density  makes  masses  more
ifﬁcult  to  detect.  However,  the  often-associated  microcal-
iﬁcations,  skin  changes,  axilliary  adenopathies  and  density
symmetries  indicate  the  diagnosis  of  a  malignant  lesion.
n  an  article  published  in  2003  on  22  patients  presenting  a
regnancy-associated  cancer,  13  of  the  15  mammographies
86.7%)  were  positive  although  only  eight  of  them  presented
asses  [6].  Two  other  studies,  in  1994  and  2006,  found  a
ositive  mammography  in  78%  and  90%  of  the  cases,  respec-
ively,  in  spite  of  the  dense  breasts  (BI-RADS  3  and  4)  [7,8].
The  MRI  with  injection  is  not  currently  recommended  in
regnancy-associated  breast  cancers.  Only  an  unquestion-
ble  indication  with  a  calculated  beneﬁts-risk  ratio  indicates
n  MRI  in  this  context  [9].  The  question  is  whether  or  not
his  technique  has  any  value  during  lactation  and  whether
he  injection  of  gadolinium  chelate  represents  a  risk.  This
uestion  also  subsists  during  the  weeks  following  the  end  of
actation.  In  fact,  the  involution  of  the  histological  changes
ainly  occurs  during  the  3  months  after  the  suspension  of
reastfeeding  [1,10]. Although  no  study  has  yet  determined
he  evolution  of  the  imaging  after  the  suspension  of  breast-
eeding,  we  can  assume  that  the  changes  in  the  imaging  are
orrelated  with  that  of  the  anatomopathology.
nalysis of the literature
njection of gadolinium chelate and
reastfeeding
oth  radiologists  and  patients  are  reticent  about  an  MRI
uring  lactation.  The  women  worry  about  the  suspension
f  breastfeeding  and  the  doctors  about  the  futility  of  this
xamination.  However,  two  recent  articles  conﬁrm  the
ossibility  of  continuing  breastfeeding  without  any  spe-
iﬁc  precautions  after  the  injection  of  gadolinium  chelate
11,12].  In  fact,  only  0.04%  of  the  injected  dose  passes  into
he  milk.  This  is  a  very  low  dose  and  less  than  one  hundredth
f  the  permissible  dose  in  the  infant  (200  m/kg)  [13]. A
hird  article  appearing  in  2007  backed  up  this  idea,  calculat-
ng  the  absorption  of  gadolinium  at  0.2%  of  the  administrable
ose  in  paediatrics  (0.1  mmol/kg)  for  an  infant  weighing
 kg  and  its  70  kg  mother  [12]. Therefore,  this  data  has  led
he  American  College  of  Obstetricians  and  Gynaecologists  to
onﬁrm  the  safety  of  breastfeeding  immediately  after  the
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xamination  [11,12]. However,  as  opposed  to  the  European
nd  American  recommendations,  the  French  recommenda-
ions  continue  to  suspend  breastfeeding  for  24  h  after  the
dministration  of  gadolinium  [14].
RI during breastfeeding
t  is  acknowledged  that  this  examination  is  limited  during
actation,  thereby  accounting  for  the  few  articles  dealing
ith  this  subject.
ase  report:  2003  [15]
n  2003,  an  article  reported  the  case  of  a  young  36-year-
ld  nursing  mother  presenting  a clinical  anomaly  with  a
egative  standard  assessment.  The  MRI  then  carried  out
id  not  detect  any  focal  anomaly  although  major  glan-
ular  changes,  with  dense  breasts,  presented  diffuse  and
eterogeneous  contrast  enhancement.  The  ﬂow  extraction
FE)  increased  (over  25)  in  a  great  many  zones  (the  ﬂow
xtraction  is  a  parameter  assessing  the  permeability,  ﬂow
nd  the  vessels  and  is  expressed  in  millilitres  of  blood,
00  mg  of  tissue/minute.  An  increase  indicates  a  possible
alignant  lesion).  In  view  of  the  negativity  of  all  of  the
xplorations,  a  biopsy-exeresis  was  carried  out.  This  con-
rmed  the  benign  histology.  The  authors  then  wondered,  if
he  lesion  was  malignant,  would  it  have  been  objectiﬁed
r,  on  the  contrary,  would  it  have  masked  the  physiological
odiﬁcations  [7]?
irst  study:  2005  [16]
n  2005,  a study  was  published  on  this  question  [8].  Three
eaders  carried  out  a  retrospective  analysis  of  breast  MRIs  on
 women  27—42  years  of  age  (mean  age:  36  years)  who  had
ursed  between  5  days  and  22  months.  Four  women  con-
inued  breastfeeding  and  three  stopped  during  the  MRI  (a
aximum  of  12  days  before).  The  MRI  indications  were  ﬁve
ases  of  an  assessment  of  the  extension  of  histologically-
roven  breast  cancer,  one  case  of  screening  in  a  woman  with
 high  genetic  risk  and  one  case  of  a  suspicion  of  breast
ngiosarcoma  after  a  skin  biopsy  (Appendix  I).  The  proto-
ol  was  standard,  including  one  T1  SE,  fast-SE  T2  sequence
ith  Fat  Sat,  dynamic  sequences  in  T1  EG,  and  one  high  res-
lution  T1  sequence.  Different  parameters  were  assessed
oncerning  the  breast  (density,  signal  in  T2  compared  with
he  pectoral  muscle,  morphological  appearance  and  dynam-
cs  of  the  enhancement),  and  the  focal  lesions  detected
morphology,  enhancement  and  dynamics  of  the  contrast
nhancement).
hysiological  modiﬁcations  of  the  breast  in  MRI
he  following  were  found  in  the  normal  breast:  an  increase
n  the  density  in  T1  weighting,  super-imposable  over  that  of
he  mammography,  a  T2  hypersignal  related  to  an  increase  in
he  free  water  and  a  dilation  of  the  galactophoric  channels
elated  to  the  milk  production.  After  injection,  as  previ-
usly  described,  the  breast  presents  diffuse,  heterogeneous
nhancement,  attesting  to  the  hypervascularisation  related
o  this  state.  The  dynamic  curve  carried  out  on  the  breast
eveals  a  fast  initial  and  then  progressive  secondary  contrast
nhancement  of  variable  intensity  in  most  cases.  Only  one
atient  presented  a  wash-out.  The  existence  of  little  dis-
inct  enhancement  of  the  retroaureolar  channels  was  noted.
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iIs  a  breast  MRI  possible  and  indicated  in  case  of  suspicion  of
This  has  never  been  described  in  the  literature  before.  Two
hypotheses  are  available  to  account  for  this:  enhancement
of  the  wall  or  excretion  of  gadolinium  in  the  milk.  All  of
these  physiological  modiﬁcations  therefore  are  due  to  the
histological  modiﬁcations  resulting  from  lactation.
Neoplasia
As  regards  the  detection  of  tumoral  lesions,  the  study  also
demonstrates  the  value  of  the  T2  Fat  Sat  sequence  dur-
ing  this  period.  In  fact,  the  glandular  hypersignal  indicates
the  hyposignal  of  inﬁltrating  ductile  carcinomas  and  in  cer-
tain  cases,  the  lineal  hyposignal  of  cancers  in  situ.  After
the  injection  of  gadolinium,  in  spite  of  the  diffuse  glandular
enhancement,  inﬁltrating  ductile  carcinomas  are  well  indi-
vidualised  since  they  are  enhanced  even  sooner  and  much
more  intensely  than  the  adjacent  parenchyma  (153%  versus
60%),  in  most  cases  with  a  wash-out.  An  annular  enhance-
ment,  a  criterion  of  malignity,  is  described  in  two  of  the  ﬁve
cases.  The  in  situ  ductile  carcinomas  described  in  this  study
present  a  segmental  or  more  diffuse  contrast,  but  are  only
objectiﬁed  in  two  patients  (versus  four  inﬁltrating  ductile
carcinomas  in  anatomopathology).  As  regards  the  suspicion
of  angiosarcoma,  neither  the  surgical  biopsy  nor  the  MRI
was  able  to  prove  the  malignity  in  this  patient.  The  18-
month  monitoring  was  also  found  to  be  negative.  Finally,  the
MRI  of  the  patient  with  a  high  genetic  risk  did  not  detect  a
tumour.
Second  study:  2007  [17]
A  second  study,  concentrating  more  on  the  performance  of
the  different  techniques  (sonography,  mammography  and
MRI)  in  the  exploration  of  masses  palpated  during  lactation
appeared  in  2007  in  Clinical  Imaging.  Among  the  27  lactating
patients,  nine  MRI  were  carried  out.  The  results  obtained
demonstrate  the  good  radio-histological  correlation  since
all  of  the  masses  classiﬁed  BI-RADS  4  or  5  in  MRI  corre-
sponded  to  inﬁltrating  ductile  carcinomas.  The.  MRI  also
allowed  for  a  reclassiﬁcation  as  BI-RADS  1  or  2  for  images
classiﬁed  as  3  in  the  standard  assessment  (mammogra-
phy/sonography).  This  was  proven  exact  (histological  proof).
Finally,  in  one  case,  the  clinical  bifocal  nature  was  conﬁrmed
(Appendix  II).
Limits  and  biases
The  two  studies  described  contradict  the  idea  that  the  MRI
is  less  efﬁcient  during  lactation.  However,  they  include  a
number  of  biases  and  limits.  First,  the  very  limited  number
of  patients  renders  the  results  non  statistically  signiﬁcant.
However,  the  MRI  indications  remain  present,  in  particular  in
D
T
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he assessment  before  and  during  neoadjuvant  chemother-
py  in  these  large  tumours.  Second,  they  are  retrospective
tudies  or  involve  large  known  lesions.  The  radiologists  are
herefore  oriented:  what  is  the  situation  for  infra-clinical
esions?  The  question  of  the  screening  of  women  with  a
igh  genetic  risk  is  raised  since  the  examination  is  often
uspended  during  a  considerable  period  of  time,  during  a
eriod  favourable  for  the  development  of  tumours.  Finally,
he  masses  studied  are  always  ductile,  the  most  frequent
istology.  According  to  the  literature,  the  distribution  of  the
istological  sub-types  does  not  change  during  pregnancy  or
actation.  However,  lobular  neoplasia,  although  more  rare,
s  also  more  difﬁcult  to  diagnose.  The  morphologies  and
nhancement  curves  in  MRI  are  variable  [18,19]  and  the
iagnosis  may  prove  to  be  difﬁcult  outside  of  any  context.
his  difﬁculty  is  most  likely  increased  during  a  period  of  lac-
ation.  However,  are  these  lobular  cancers  occurring  during
actation  unexplorable  by  this  technique?
The  radio-histological  comparison  is  also  insufﬁcient.
n  the  ﬁrst  study  on  ﬁve  neoplasias,  only  two  analyses
mmediately  after  the  examination  were  recovered  (among
he  three  anatomopathological  studies,  one  was  carried
ut  in  another  centre,  the  other  two  after  neoadjuvant
hemotherapy).  Therefore,  it  was  only  possible  to  compare
he  estimated  size  in  sonography  and  MRI  with  the  real  size
f  the  tumour  in  one  case.  A  signiﬁcant  difference  in  the  size
f  the  masses  is  noted  between  the  two  techniques  in  one
atient:  6.7  cm  in  MRI  versus  3.4  cm  in  sonography  without
natomopathology  to  make  sure  of  the  real  correspondence.
onclusion
n  conclusion,  these  studies  are  imperfect.  However,  they
ack  up  the  idea  that  MR  imaging  is  not  void  of  value  during
actation.  The  MRI  has  its  own  semiology  during  lactation,
elated  to  the  physiological  changes.  Even  so,  it  remains
fﬁcient,  allowing  for  the  satisfactory  detection  according
o  the  BI-RADS  classiﬁcation  of  tumours  by  the  ACR.  The  MRI
nd  the  injection  of  gadolinium  chelate  also  seem  to  be  risk
ree  during  breastfeeding  both  for  the  mother  and  the  child.
owever,  the  suspension  of  breastfeeding  for  24  h  after  the
njection  remains  recommended  in  France.isclosure of interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
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ppendix I. Details on the ﬁve patients presenting breast cancer in the 2005 study [16].
Patient  1  Patient  2  Patient  3  Patient  4  Patient  5
natomopathology
Type CCI CCI  CCI  CCI  CCI
Size  (cm) NC NCa 1,2 1,9 NCa
Multifocality  NC  NCa No  Yes  NCa
Associated  CCIS  Yes  No  Yes  Yes  Yes
onography  (hypoechogenic  mass)
Sonography  (cm)  3,4  2  NC  1,5  3.2/1.2/3.1
Multifocality  or
extensive
tumour
No No  No  No  Yes
RI
Description  of
the  mass
Heterogeneous
enhancement
of  the  masse
Annular
enhancement
Annular
enhancement
Homogeneous
enhancement
of the  masse
Heterogeneous
of half  of  the
breast
Size  (cm) 6.7 1.6  NC  1.2  8
Anatomopathological analysis carried out in another establishment, data missing.
Initial size not known (adjuvant chemotheraphy).
ppendix II. Details on the nine patients in the 2007 study [17].
Age  Palpable
mass
BI-RADS
sonography
BI-RADS
mammography
MRI  Decision  Histology
atient  1  33 Left
First
seat
5 5  4  Surgery  Bifocal  CCI
Last  seat  —  —  4
atient  2  32  Right  3  3  5  Cytopuncture  and  Surgery  CCI
atient  3  33  Left  3  4  4  Cytopuncture  and  Surgery  CCI
atient  4 35 Left  4  3  4  Surgery  CCI
atient  5  33  Left  2  3  3  Biopsy  Papilloma
atient  6 32 Left 3 3  3  Cytopuncture  Hyperplasia
atient  7  41  Right  3  1  3  Biopsy  Mastopathy
atient  8  35  Right  2  1  Monitoring  Not  known
atient  9  31  Right  3  1  2  Biopsy  Parenchyma
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